1.Meningitis as early manifestation of anti-NMDAR encephalitis
Sirichai Kittichanteera ; Metha Apiwattanakul
Neurology Asia 2014;19(4):413-415
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a recently discovered immune mediated
encephalitis. The syndrome typically occurs in children and young adult with initial presentations
of psychiatric symptoms, seizures, followed by abnormal movement and dysautonomia. There is
association with ovarian teratoma. We report here a 16-year-old girl with anti-NMDAR encephalitis,
who present with meningitis as initial symptom, confirmed by pleocytosis in the cerebrospinal fluid
and leptomeningeal enhancement in MRI. She subsequently manifested the more typical manifestations
of oro-facial dyskinesia and choreoathetosis. The diagnosis was confirmed by the presence of antiNMDAR
antibody. She was treated with immunotherapy with clinical improvement and drop in the
level of autoantibody. However the patient died due to septisemia.
2.The use of AQP4-antibody testing in diagnosis Thai patients with neuromyelitis optica
Sasitorn Siritho ; Metha Apiwattanakul ; Naraporn Prayoonwiwat
Neurology Asia 2014;19(4):375-385
Background: There are several methods to detect AQP4-antibody which is essential for diagnosis
neuromyelitis optica (NMO). Objective: To evaluate an accuracy of the commercially available kit
compared with other available tests. Methods: One hundred and twelve patients who visited the
multiple sclerosis (MS) clinic at Siriraj Hospital were tested for AQP4-antibody by cell-based assay
with Sendai method (Postfix-CBA), a commercial kit (Prefix-CBA) and an indirect immunofluorescence
tissue-based assay (IIF-TBA). The patients were classified to NMO, seropositive NMOSD (AQP4-pos
NMOSD), seronegative NMOSD (AQP4-neg NMOSD), classic MS (CMS), atypical MS and clinical
isolated syndrome (CIS). Results: Based on postfix-CBA, there were 26 NMO, 25 AQP4-pos NMOSD,
19 AQP4-neg NMOSD, 34 CMS, 4 atypical MS and 14 CIS. There were 5 (1 NMO, 2 AQP4-neg
NMOSD, 2 CMS), 7 (1 NMO, 6 AQP4-pos NMOSD) and 2 patients (1 AQP4-neg NMOSD, 1 CIS)
were seropositive only by CBA-kit, CBA-Sendai and IIF-TBA respectively. Sixteen patients were
seropositive by both CBA but negative by IIF-TBA. Both CBA showed strong correlation.
Conclusions: CBA-kit is a relatively sensitive, comparable assay to detect anti-AQP4 antibody in Thai
NMO patients. Since the kit may have a few false-negative and false-positive results, a more sensitive
assay is necessary for a much more proper diagnosis in the future.
3.Isolated bulbar palsy with anti-GM3 and GT1b antibodies
Narongrit Kasemsap ; Kannikar Kongbunkiat ; Metha Apiwattanakul ; Kittisak Sawanyawisuth ; Somsak Tiamkao
Neurology Asia 2013;18(3):319-321
Isolated acute bulbar palsy has been described as one of the more rare variants of Guillain-Barré
syndrome. IgG anti-ganglioside antibodies are associated with axonal subtypes of Guillain-Barré
syndrome as well as Fisher syndrome. However, IgG against GM3 and GT1b in relation to bulbar
palsy is uncommon. In this case report, we describe a 64 year-old male patient presenting with
isolated bulbar weakness and generalized hyporeflexia without limb weakness. Serological testing
for antiganglioside antibodies was positive for IgG anti-GM3 and -GT1b, suggesting the association
of these antibodies with isolated bulbar palsy.